Michelle Arbus is the VP/Research at Strainprint Technologies. As such, she oversees research products and helps understand, both from a patient and researcher perspective, how, when, why and what patients are using to treat conditions and indications. Strainprint is a partner for Cannabis + Technology on September 27, 2019 in Toronto.
Cannabis Criminalization ‘Does Little To Curtail Use’ New Poll Finds
Cannabis criminalization ‘does little to curtail use’ according to a new study, which found only a 1.1% difference in regular...